key: cord-0741790-f4hyushd
authors: Ranganathan, Chakrapani; Fusinski, Shelley D.; Obeid, Imad M.; Ismail, Khaled M.; Ferguson, Derrick T.; Raminick, Mindy F.; Dawes, Sean M.
title: Therapeutic plasma exchange for persistent encephalopathy associated with Covid-19
date: 2021-02-07
journal: eNeurologicalSci
DOI: 10.1016/j.ensci.2021.100327
sha: 6b4f4e4db83f0a247d3df19329773c143ed4fa83
doc_id: 741790
cord_uid: f4hyushd

Patients infected with COVID-19 virus, show a highly variable symptomatology which can include central nervous system (CNS) dysfunction. One of the most disabling CNS manifestations is persistent severe encephalopathy seen for weeks after the resolution of the acute viral pneumonia and associated acute systemic illnesses. The precise pathophysiology of this persistent Post COVID Encephalopathy is unknown but may involve direct viral invasion of microvascular endothelium, microvascular thrombosis, toxic neuronal effects of inflammatory products, vasoactive pathology at arteriolar level or leptomeningeal inflammation. Currently, there are no established specific treatments for Post COVID -19 encephalopathy. We present a case series of three patients that underwent Therapeutic Plasma Exchange (TPE) with salinized albumin that suggests a positive therapeutic effect. We believe that the results warrant further evaluation for the role of TPE with a prospective randomized trial in persistent Post COVID -19 encephalopathy syndrome.

stimulus. During this initial evaluation the patient was noted to have episodic tonic vertical gaze deviation raising concern for seizure. A stat EEG demonstrated a slow disorganized alpha rhythm at 7Hz with moderately increased polymorphic theta delta activity bilaterally with slight right sided predominance and several brief clusters of sharp waves over the right hemisphere.

Since the patient was already on a low dose of valproate sodium for other indications, the dosage was increased to raise the Valproate serum levels to therapeutic range for seizure disorder. As part of the work-up for his encephalopathy, imaging studies were obtained. Noncontrast CT Brain did not reveal any acute intracranial process but did reveal a pattern suggestive of moderate chronic small vessel disease in periventricular white matter bilaterally in cerebral hemispheres. CT perfusion study of brain revealed a pattern of small vessel ischemia with bilateral perfusion deficits in inferior frontal lobes, right cerebellum temporoparietal areas.

CT angiography did not reveal any large vessel occlusion. MRI revealed chronic bilateral small vessel related ischemic changes but no findings consistent with acute process. A second EEG was obtained demonstrating a severe encephalopathic pattern without epileptiform discharges. on alternate days for a total of five treatments. Mental status significantly improved in each of these three cases after TPE, both clinically and on EEG (see Table) . It is possible that despite adequate peripheral arterial blood pressure the brain suffers hypoperfusion, potentially Fortunately, weeks after being in a severe encephalopathic state, the toxic effects on the central nervous system were found to be reversible after TPE. In addition to the improvements seen in CNS function, a small randomized trial in patients with severe Covid-19 is reported that found that TPE was associated with higher extubation rates and decreased 14 day and 28-day mortality, providing further support for the potential role of TPE in Covid-19 14 .

Based on these results, a placebo-controlled randomized or case-controlled study for the role of plasma exchange with albumin, in COVID-19 patients with persistent encephalopathy is felt warranted. This may be done with additional monitoring of cerebral perfusion and the measurements of inflammatory mediators to clarify the mechanisms in play. If such objective studies can confirm the findings noted in these three case reports, then the plasma exchange with albumin, could be utilized as an effective treatment in those COVID-19 patients with severe persistent encephalopathy. Plasma exchange may hopefully rescue some of these unfortunate patients from their prolonged comatose states.

Central Nervous System Complications in COVID-19 Patients; a Systematic Review and Meta Analysis based on Current Evidence

Diagnosis and Treatment of Adults with Community acquired Pneumonia. An Official Clinical Practice Guideline of the

Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients

Nervous system involvement after infection with COVID-19 and other coronaviruses

Neurologic Manifestations of Hospitalized Patients With CoronavirusDisease

Neurological Complications of Coronavirus Disease(COVID-19): Encephalopathy. Cureus

Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in

Mice Transgenic forHuman ACE2

Effects of COVID-19 on the Nervous System

COVID-19 as a Blood Clotting Disorder Masquerading as a Respiratory Illness: A Cerebrovascular Perspective and Therapeutic Implications for Stroke Thrombectomy

Therapeutic plasma exchange in adults with severe COVID-19 infection

Neuropathology of patients with COVID-19 in Germany: a post-mortem case series

Therapeutic Plasma Exchange -An Emerging Treatment Modality in Patients with Neurologic and Non-Neurologic Diseases

Application of Plasma Exchange in Steroid-Responsive Encephalopathy

SARS-CoV-2 Detected in Cerebrospinal Fluid by PCR in